Cleary Seals $495M Simcere Sale To Founder, Partners
Simcere Pharmaceutical Group will go private in a sweetened $495 million sale to a consortium led by its founder, it said Wednesday, fueling a trend of companies delisting in favor of...To view the full article, register now.
Already a subscriber? Click here to view full article